Services - Boehringer Ingelheim Therapeutics in Ochsenhausen, Germany
Labor Ochsenhausen, lab Germany, lab Europe, lab Germany manufacturing, lab Germany Virology, lab Germany Microbiology, lab Germany Immunology, lab Germany Toxicology, lab Deutschland manufacturing, lab Deutschland Microbiology, lab Deutschland Immunology, lab Deutschland Toxicology, manucaturing, virology, microbiology, immunology, toxicology, contract manufacturing testing servieces, virology, microbiology, immunology, toxicology, bioassys, analytics
397
page-template,page-template-full_width,page-template-full_width-php,page,page-id-397,page-parent,ajax_fade,page_not_loaded,,qode-title-hidden,qode_grid_1300,footer_responsive_adv,qode-child-theme-ver-1.0.0,qode-theme-ver-13.6,qode-theme-bridge,disabled_footer_top,wpb-js-composer js-comp-ver-6.7.0,vc_responsive
Labor Dr.Merk has the highest standards for bioassays incorporated in preclinical development, batch release, and stability testing.
Labor Dr.Merk Virology

Bioassays

The center of excellence at Boehringer Ingelheim Therapeutics ensures the highest standards for bioassays incorporated in preclinical development, batch release, and stability testing.

Virology

Boehringer Ingelheim Therapeutics has been pioneering the field of virology for over 40 years and can build upon an extensive experience in viral clearance studies, raw material testing, vaccine release and viral disinfectant testing. Using more than 40 different high titer purified virus strains from animal and human origin, a wide range of potential viral contaminants can be covered.
Antimicrobial susceptibility testing in petri dish

Microbiology

Boehringer Ingelheim Therapeutics has implemented a broad range of microbiological and biochemical methods to develop as well as test the efficacy of manual or automated cleaning and disinfection processes. Customized microbiological safety studies for biopharmaceutical industries and medical device manufacturers, including monitoring of clean rooms, support product safety of clients.

Analytics

Boehringer Ingelheim Therapeutics performs a broad spectrum of physicochemical methods analyzing characteristics like content, purity, impurity, efficacy and safety of biologicals like antibodies, viral therapeutics, vaccines, and a variety of bio- and – cell-based-bioassays. Differentiating and determining empty and full capsids, infectious and genomic virus particles, and virus aggregates are only a small excerpt of Boehringer Ingelheim Therapeutics analytical capabilities.
Labor Dr.Merk has the highest standards for bioassays incorporated in preclinical development, batch release, and stability testing.

Bioassays

The center of excellence at Boehringer Ingelheim Therapeutics ensures the highest standards for bioassays incorporated in preclinical development, batch release, and stability testing.
Labor Dr.Merk Virology

Virology

Boehringer Ingelheim Therapeutics has been pioneering the field of virology for over 40 years and can build upon an extensive experience in viral clearance studies, raw material testing, vaccine release and viral disinfectant testing. Using more than 40 different high titer purified virus strains from animal and human origin, a wide range of potential viral contaminants can be covered.
Antimicrobial susceptibility testing in petri dish

Microbiology

Boehringer Ingelheim Therapeutics has implemented a broad range of microbiological and biochemical methods to develop as well as test the efficacy of manual or automated cleaning and disinfection processes. Customized microbiological safety studies for biopharmaceutical industries and medical device manufacturers, including monitoring of clean rooms, support product safety of clients.

Analytics

Boehringer Ingelheim Therapeutics performs a broad spectrum of physicochemical methods analyzing characteristics like content, purity, impurity, efficacy and safety of biologicals like antibodies, viral therapeutics, vaccines, and a variety of bio- and – cell-based-bioassays. Differentiating and determining empty and full capsids, infectious and genomic virus particles, and virus aggregates are only a small excerpt of Boehringer Ingelheim Therapeutics analytical capabilities.